10/16/2026
Advancing breast cancer diagnostics through precision immunohistochemistry!
Breast Cancer Awareness Month is an opportunity to recognize both the people affected by breast cancer and the scientific infrastructure that supports evidence-based care. In breast pathology, ER and PR assessment, HER2 evaluation, and the complementary interpretation of proliferation markers such as Ki-67 contribute to tumor characterization. GATA3 may support identification of mammary differentiation as part of an appropriate panel.
Every Marker Matters. Every Diagnosis Matters. Every Patient Matters.